Mitigating potential risk for stakeholders in light of latest Sunshine Act developments.
Kim Schroer
Advertisement
Articles by Kim Schroer
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
TrumpRx and the Dawn of Direct-to-Consumer Commercialization
2
FDA Approves Bayer’s Lynkuet as First Dual Neurokinin Antagonist for Menopausal Hot Flashes
3
FDA Approves Blenrep for Treatment of Replapsed/Refractory Multiple Myeloma
4
Lilly Enters Definitive Agreement Acquiring Aderum Biotechnologies
5
